ProMotion EV1 Logo-01

Dear Member

I hope you enjoyed the FMPA virtual conference and that you managed to visit the ProMOTION EV1 virtual stand. If you missed us, you can watch our quick product video and find more information over on our website.

I wanted personally to introduce our company as we’re now the FMPA’s lead sponsor for the next 3 seasons.

I also wanted to inform you that, as an FMPA member, you can enjoy 20% off if you pre-order a ProMOTION EV1 before September 2021.

We look forward to meeting you in person so you can experience the unique capabilities of this innovative new device for yourself.


ProMOTION EV1 is a unique device that provides hot, cold or contrast therapy, between the ranges of 6°C – 40°C, compression from 20mmHg to 75mmHg. Elite athletes and sporting individuals can use it for musculoskeletal aches, pains, strains and injuries across the body.

ProMOTION EV1 is fully portable and battery operated, with no need for ice, water or tethering. You can also:

  • Download data to monitor the exact usage of the device
  • Use pre-determined programmes
  • Pre-programme tailored treatments
  • Remotely control treatments through the app


Our therapeutic device has been researched, designed and developed by Swellaway Limited. Elite professional Football, Rugby Union and Rugby League clubs have all been involved in developing the product over a number of years.

ProMOTION EV1 was an integral part of Harry Maguire’s recovery programme to be fit for the Euros this summer.

Harry Maguire said “ProMOTION EV1 definitely improved the expected timescale of my recovery 100%. I am looked after by some of the world’s greatest medical staff at both Manchester United and England, but they cannot be with me 24 hours a day but my ProMOTION EV1 can.”


ProMOTION EV1 is the first product based on new technology and science developed alongside researchers from the University of Central Lancashire and Manchester Metropolitan University.

Within our Knowledge Transfer Partnership, the device has been through years of trials and rigorous testing with professional teams and leading academics to optimise safety and performance.


The guidelines for injury management have introduced ‘optimal loading’ as a solution to encourage early activity to optimise recovery.

Previous studies have identified potential adverse effects on muscle strength and dynamic stability following ice treatment. However, evidence supports the use of cryotherapy to provide short-term pain relief for soft tissue injury.

Emerging research has now shown that targeted cryotherapy, such as that offered by ProMOTION EV1, has the potential to provide the desired short-term pain relief and minimise the adverse effects of cooling. This allows players to return to weight-bearing activity earlier, at a lower risk of re-injury post-intervention.

ProMOTION EV1 has been developed with such research in mind. We take a scientific approach to improving the treatment solutions available for musculoskeletal injuries in elite sport.

If you would like any of the publications which support the use of ProMOTION EV1’s targeted cryotherapy, please get in touch.


If you would like a demonstration of the technology, please do not hesitate to contact our Commercial Director, Rebecca Woodley-Jones at [email protected] or log your interest on our website.

Yours sincerely

Rebecca Woodley-Jones